SCHEMBL20182203

SCHEMBL20182203

N#Cc1c(-c2cnc(C(F)(F)F)nc2)c2c(N)ncnc2n1C/C(=C/Nc1ccccc1F)N=N

nearest known ligand 0.37

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CFTR P13569 17/20 0.37
LRRK2 Q5S007 1/20 0.34
LCK P06239 1/20 0.32
KDR P35968 1/20 0.32
TEK Q02763 1/20 0.32
RPS6KA3 P51812 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20181900 0.87 KDR (0.37) LRRK2LCKKDRTEKRPS6KA3
SCHEMBL20182220 0.82 CFTR (0.39) CFTRLRRK2LCKKDRTEK
SCHEMBL20182263 0.81 CFTR (0.40) CFTRLRRK2
SCHEMBL20182360 0.77 FYN (0.35) LRRK2LCKKDRTEKRPS6KA3
SCHEMBL20182269 0.76 CFTR (0.38) CFTRLRRK2
SCHEMBL20182281 0.76 FLT3 (0.39) CFTR
SCHEMBL20182280 0.75 CFTR (0.38) CFTRLRRK2KDRTEK
SCHEMBL20181896 0.74 CFTR (0.42) CFTR
SCHEMBL20182354 0.74 CFTR (0.41) CFTRLRRK2KDRTEK
SCHEMBL29768981 0.72 CFTR (0.59) CFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018094137-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) 2018-05-24 WO disclosed